Discovery and development of folic acid based receptor targeting started in late 1991 and early 1992 when researchers came to know that folate receptors (FR) are over expressed on malignant tissues. The malignant tissues over express special folate receptors to capture more folate from the blood stream as folate is required for cell division. The researchers found that folate can be used as an optimal targeting ligand that would bind selectively to pathologic cells, displaying no affinity for healthy cells. Then they focused on attaching a drug molecule to the folate ligand that can be delivered directly to the cells which led to the discovery of tumor-selective drug delivery system. In tumor-selective drug delivery folic acid till date has...
Over expression of Folate receptors in a variety of tumors led to the discovery of folate receptor b...
A variety of human cancer cells and inflammatory macrophages over-express the receptor that binds fo...
Over the last 25+ years, the folate receptor (FR) has emerged as an attractive tumor biomarker with ...
Discovery and development of folic acid based receptor targeting started in late 1991 and early 1992...
In recent years methods of selective targeting of pathologic cells have become increasingly importan...
In this thesis, folate conjugates with imaging agents are studied as tumor tissue diagnostics. The l...
The folate receptor has achieved great importance for use in targeted drug delivery and in vitro and...
Folate receptors (FRs) are over-expressed on many tumor cell surfaces compared to most normal tissue...
Folic acid has been frequently exploited for target therapies geared toward overexpressed folate rec...
In this literature thesis, the folate-fluorescein-PEG-biotin (FFPB) complex and ligand have been suc...
Folate receptor-targeted imaging agents have previously been utilized to image and diagnose both can...
The high affinity folate receptor (FR) is overexpressed on approximately 80% of all cancer types and...
Folate-targeted drug delivery is a means by which therapeutic and imaging agents may be selectively ...
Folic acid can combine specifically with folate receptors (FRs) which are overexpressed on the epith...
The discovery of high levels of the folate receptor (FR) on human tumor cells has rendered this fola...
Over expression of Folate receptors in a variety of tumors led to the discovery of folate receptor b...
A variety of human cancer cells and inflammatory macrophages over-express the receptor that binds fo...
Over the last 25+ years, the folate receptor (FR) has emerged as an attractive tumor biomarker with ...
Discovery and development of folic acid based receptor targeting started in late 1991 and early 1992...
In recent years methods of selective targeting of pathologic cells have become increasingly importan...
In this thesis, folate conjugates with imaging agents are studied as tumor tissue diagnostics. The l...
The folate receptor has achieved great importance for use in targeted drug delivery and in vitro and...
Folate receptors (FRs) are over-expressed on many tumor cell surfaces compared to most normal tissue...
Folic acid has been frequently exploited for target therapies geared toward overexpressed folate rec...
In this literature thesis, the folate-fluorescein-PEG-biotin (FFPB) complex and ligand have been suc...
Folate receptor-targeted imaging agents have previously been utilized to image and diagnose both can...
The high affinity folate receptor (FR) is overexpressed on approximately 80% of all cancer types and...
Folate-targeted drug delivery is a means by which therapeutic and imaging agents may be selectively ...
Folic acid can combine specifically with folate receptors (FRs) which are overexpressed on the epith...
The discovery of high levels of the folate receptor (FR) on human tumor cells has rendered this fola...
Over expression of Folate receptors in a variety of tumors led to the discovery of folate receptor b...
A variety of human cancer cells and inflammatory macrophages over-express the receptor that binds fo...
Over the last 25+ years, the folate receptor (FR) has emerged as an attractive tumor biomarker with ...